Omani Rial strengthens sharply against Indian Rupee amid tariff shock
The Omani Rial has surged in value against the Indian Rupee, offering a golden remittance window for Indian expatriates in the Sultanate. Triggered by U.S. President Donald Trump's surprise announcement of a 25% tariff on Indian exports, the rupee slumped to a five-month low, pushing the exchange rate past ₹227 per Omani Rial — a level not seen since February.
At around 11 a.m. today, Bank Muscat quoted an exchange rate of ₹226.398, while private exchange houses offered as much as ₹226.70. Currency platform xe.com showed rates nearing ₹227.68, reflecting high market volatility. The Reserve Bank of India (RBI) is expected to step in to cushion the fall if the rupee edges closer to its all-time low of ₹87.95 against the U.S. dollar.
Many Indian expatriates in Oman, particularly those who receive their salaries at month-end, are rushing to take advantage of the windfall. Santhosh Kumar, a Keralite working with a car parts firm, said, 'I've been saving up for this moment. With the salary just in, I'm sending the money today itself. This is the best rate we've seen in months.' The drop in the rupee's value means expats now receive significantly more in rupee terms for each rial remitted — a boon amid rising living costs and financial obligations back home.
In a message to customers, Nixon Baby, General Manager of Joyalukkas Exchange LLC, Oman, noted: 'The Indian Rupee has recently shown a weakening trend… With the current exchange rate favoring the Omani Rial, now is a prudent time to consider sending money back home, as remittance can yield higher value in India.' He added that while the rupee may remain volatile in the short term, analysts expect the phase to be temporary. 'Timing your remittance during such dips is key to maximizing value,' the statement read.
The Indian Rupee has recently shown a weakening trend… With the current exchange rate favoring the Omani Rial, now is a prudent time to consider sending money back home, as remittance can yield higher value in India.
-Nixon Baby, General Manager of Joyalukkas Exchange -
The rupee's decline today was steep, opening at ₹87.69 per dollar and slipping to ₹87.74 before partially recovering. The Indian central bank is widely expected to step in to limit further depreciation, though it may not aggressively defend a fixed level. India's equity markets mirrored the nervousness: the BSE Sensex dropped over 600 points, while the Nifty50 fell 189 points (0.76%), led by export-heavy sectors like IT, pharmaceuticals, textiles, and auto. The pressure is compounded by foreign capital outflows, with $425 million exiting Indian equities and $4.6 million from bonds on July 29 alone. Meanwhile, U.S. Treasury yields rose to 4.36%, signaling a flight to safety amid growing trade tensions.
As New Delhi studies the implications of Trump's tariff decision, analysts suggest that the current shock may be mitigated if India and the U.S. can reach a trade compromise. Until then, uncertainty is likely to keep the rupee under pressure — a scenario that could continue to benefit Omani remitters in the near term.
For now, the currency swing has handed a rare tactical advantage to Indian expats in Oman, many of whom are seizing the moment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Observer
14 hours ago
- Observer
With new 40% Tariff, Trump tries to box in China
Ever since President Donald Trump began raising tariffs on goods from China during his first term, Chinese companies have raced to set up warehouses and factories in Southeast Asia, Mexico and elsewhere to bypass US tariffs with indirect shipments to the US market via other countries. But on Thursday, Trump took aim at all indirect American imports, which he blames for part of the $1.2 trillion US trade deficit. The president imposed 40 per cent tariffs on so-called transshipments, which will take effect in a week. And a senior administration official who briefed reporters said work was underway that could broaden considerably the definition of indirect shipments. The new rules cover indirect shipments from anywhere, not just China. But China, with its massive factory infrastructure and expansive manufacturing ambition, has been the main country to develop a global network for such shipments. Trade experts were quick to predict that China would be the most affected — and the most annoyed. 'The trade provisions are a thinly veiled attempt to box in China — China will view them as such, and this will inevitably spill over into trade discussions with the United States,' said Stephen Olson, a former US trade negotiator who is now a senior fellow at the ISEAS-Yusof Ishak Institute, a research group in Singapore. Trump's executive order Thursday created a new category of imports: goods that are transshipped through other countries instead of coming straight from the country of origin. The 40 per cent tariffs on these goods will be on top of whatever tariffs would have applied if the goods had come directly from the country where they were originally made. The legal definition of transshipment is quite narrow: a good that did not undergo a 'substantial transformation' in the country through which it was indirectly shipped. Countries in Southeast Asia like Vietnam have long denied that they allow a lot of transshipment, and they have been tightening inspections to prevent it. They contend that their soaring imports of Chinese components are being assembled into new and different products that can appropriately be labeled as made in their countries, and not labeled 'made in China.' In addition to the new 40 per cent tariffs on transshipment, the Trump administration plans to put in place so-called rules of origin for indirect shipments in 'a few weeks,' the senior administration official said. Rules of origin are meant to assure importers that goods really were manufactured where their sellers say they were. To be effective, rules of origin must be written strictly, as they are for goods to qualify for free trade agreements with the United States. For example, the United States-Mexico-Canada Agreement, which replaced the North American Free Trade Agreement, require that as much as 75 per cent of cars be manufactured in North America to qualify for duty-free treatment in crossing borders. Brad Setser, an official under the Obama and Biden administrations who is now a senior fellow at the Council on Foreign Relations, said that setting rules of origin could make a big difference. 'The most significant long-term change from the Trump tariff barrage may be creating rules of origin that define the Chinese content,' he said. But other experts were less convinced that the Trump administration would set stringent rules, particularly when discussions have been underway for a possible summit this autumn between Trump and Xi Jinping, China's top leader. The Chinese government has called for the removal of tariffs on its exports and further tightened its considerable restrictions on the purchase of American goods. Workers at a clothing factory in Ho Chi Minh, Vietnam, where 60 percent of fabrics for manufacturing come from China. — NYT 'There is nothing in there about content from certain countries, and that is helpful because it means that they aren't risking the wrath of China at this point in time,' said Deborah Elms, the head of trade policy at the Hinrich Foundation in Singapore. The first country-specific trade deal reached by Trump to tackle transshipment head on was one on July 2 with Vietnam. It included a 40 per cent provision on goods indirectly shipped from China. The provision has turned out to be a blueprint for a sweeping new strategy to limit China's role in the world's supply chain. But a month later, Vietnam has not publicly confirmed the transshipment provision. With the exception of Indonesia, transshipment tariffs also have not been featured in announcements of subsequent deals with other countries in Southeast Asia. In recent weeks, Trump has also modulated his strident tone on China. He reversed a previously hard-line position on the export of artificial intelligence chips to China. Not long after, he told the president of the Philippines that he didn't mind if the country got along with China because the United States also had a good relationship with China. For countries in Southeast Asia that had raced to placate Trump over the months since he first announced his reciprocal tariffs, the flip-flopping has created both a sense of uncertainty and a dose of cynicism about the new agreements they have with the United States. At the same time, many countries in Southeast Asia have explored ways to crack down on Chinese companies that reroute exports through their countries without doing any further processing. Governments in the region have streamlined customs practices and promised to quash counterfeit and illegal trade. They have given serious thought to reducing the amount of Chinese content in the products they assemble and export. Multinationals like Walmart account for a sizable share of US imports and have fairly detailed information on how their products are made. But some analysts question whether US Customs and Border Enforcement is capable of identifying whether packages really come from China. 'Enforcement is likely to be challenging, and even if outright rerouting is reduced, trade diversion will continue to dampen the impact of US tariffs on China's aggregate export performance,' Capital Economics, an economic analysis consulting firm, said in a research note. — The New York Times
Times of Oman
18 hours ago
- Times of Oman
India may face annual export loss of $5-6.75 billion because of 25% tariffs imposed by US: Report
New Delhi: India may face an annual export loss of $5 to $6.75 billion if demand declines by 20 to 30 per cent because of 15 per cent tariff imposed by US, said a report by Ventura Securities. Given the country's FY25 GDP of around USD 3.3 trillion (Rs 287 lakh crore), this shortfall could reduce GDP growth by approximately 0.15 to 0.2 per cent, the report added. It further said that India's industry is expected to face short- to medium-term challenges due to US tariffs, however, during this period, the sector is likely to step up efforts to diversify its markets, with aim to maintain growth momentum. US President Donald Trump has imposed 25 per cent tariff on goods from India and an additional penalty if India imports crude from Russia. However, Ventura report highlighted that even with a 25 per cent US tariff, India is still competitive. "While export volumes are bound to be impacted, India can cushion much of the impact by leveraging the recently concluded FTAs with Australia, UAE, EFTA, ASEAN, and SAARC countries," the report added. While the sanctions are effective from today, higher tariffs will be imposed from August 7 onwards till a bilateral trade agreement is signed with the U.S. India continues to engage with the American counterparts to iron out the trade deal. "Negotiations are expected to resume mid-August and the deal is likely to be clinched by October. In this case, the pain would be relatively short-term with an improved trade trajectory," the report added. Over the past few months, India and the US have been negotiating for an interim trade deal, but there were some reservations from the Indian side on the US demand for opening up the agricultural and dairy sectors for the US. Agriculture and dairy are critical for India as these two sectors provide livelihood opportunities to a large section of its people. India reportedly faces US demands, including allowing remanufactured goods, opening up agriculture and dairy, accepting genetically modified (GM) feed, and adopting US rules on digital trade and product standards. Experts have stated that the decision will have a varied impact on different sectors.
Times of Oman
20 hours ago
- Times of Oman
Pharma businesses ready with contingency plans faced with US tariffs: Association of Healthcare Providers (India)
New Delhi: Indian pharmaceutical manufacturers are preparing a two-pronged strategy to offset the impact of the soon-to-be-effective 25 per cent US tariff on Indian goods, which includes drug exports, with industry experts anticipating that the move could significantly raise medicine costs in the American market. Girdhar Gyani, Director General of the Association of Healthcare Providers (India), has voiced concern over the financial burden the proposed US tariff would impose on both Indian exporters and American consumers. India currently supplies around 47 per cent of the US pharmaceutical market, largely in the form of affordable generics. "If the United States enforces this 25 per cent tariff, the cost of drug delivery in the US will inevitably rise. Our estimates show that American drug prices could increase by 20 to 25 per cent annually -- a burden of nearly USD 6 to USD 7 billion. It's unclear whether the US healthcare system can absorb such an impact," Gyani said. According to its website, the Association of Healthcare Providers (India) , a non-profit organisation, represents the majority of healthcare providers in India. Despite the initial blow to Indian manufacturers, Gyani stated that industry players are already preparing contingency plans. One such measure is ramping up production in US-based and Mexico-based facilities owned by Indian firms, which, according to Gyani, would bypass the tariff restrictions. "The second approach involves a shift in focus from basic generics to value-added combination drugs. These combination drugs, which offer the convenience of two medicines in one, can be priced higher despite having similar production costs," he noted. The goal is to increase the volume and price range of such drugs, thereby maintaining competitiveness even under the new tariff regime. Gyani also suggested that continued diplomatic engagement between New Delhi and Washington could help mitigate the situation. "Negotiations between the two governments are likely to continue, and we may eventually see a reduction or reconsideration of the tariff policy," he said. The executive order signed by President Donald Trump on Thursday has imposed a flat 25 per cent tariff on all goods from India, with no product-level exemptions. The pharmaceutical sector has been a key pillar of India-US trade relations.
